Aylin AYRIM, Nilgün TURHAN, Aslıhan PEKEL, Ömer BAYRAK

ICSI outcome in severely oligoasthenozoospermic patients and its relationship to prewash progressive sperm motility

Amaç: İCSİ yapılan ciddi oligoastenozoospermik hastalarda yıkama öncesi progresif sperm motilitesi ile gebelik oranı arasındaki ilişkiyi araştırmak. Yöntem ve gereç: Ciddi oligoastenozoospermi (

Yıkama öncesi progresif sperm motilitesinin ciddi oligoastenozoospermisi olan hastalarda İCSİ sonuçları üzerine etkisi

Aim: To investigate the association between prewash progressive sperm motility and pregnancy rate in cases of severely oligoasthenozoospermic patients in intracytoplasmic sperm injection (ICSI) cycles. Materials and methods: The study included 80 infertile couples who were treated by ICSI due to severe oligoasthenozoospermia (

PDF

___

1. Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet 1978; 2: 366.
2. Pagidas K, Falcone T, Hemmings R, Miron P. Comparison of reoperation for moderate (stage 3) and severe (stage 4) endometriosis-related infertility with in vitro fertilizationembryo transfer. Fertil Steril 1996; 65: 791-5.
3. Pagidas K, Hemmings R, Falcone T, Miron P. The effect of antisperm autoantibodies in male or female partners undergoing in vitro fertilization-embryo transfer. Fertil Steril 1994; 62: 363-9.
4. Palermo G, Joris H, Devroey P, Van Steirteghem A. Pregnancies aft er intracytoplasmic sperm injection of single spermatozoon into an oocyte. Lancet 1992; 2: 17-8.
5. Van Steirteghem A, Nagy Z, Joris H, Liu J, Staessen C, Smitz J et al. High fertilization and implantation rates aft er intracytoplasmic sperm injection. Hum Reprod 1993; 8: 1061- 6.
6. Wang YA, Dean J, Grayson N, Sullivan EA. Assisted reproduction technology in Australia and New Zealand 2004. Canberra: Australian Institute of Health and Welfare; 2006.
7. Wright VC, Chang J, Jeng G, Chen M, Macaluso M. Assisted reproductive technology surveillance, United States, 2004. MMWR Surveill Summ 2007; 56: 1-22.
8. Nyboe Anderson A, Goossens V, Ferraretti AP, Bhattacharya B, Felberbaum R, de Mouzon J et al. Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHRE. Hum Reprod 2008; 23: 756-71.
9. Jain T, Gupta RS. Trends in the use of intracytoplasmic sperm injection in the United States. N Engl J Med 2007; 357: 251-7.
10. Carlsen E, Giwercman A, Keiding N, Skakkebæk NE. Evidence for decreasing quality of semen during the past 50 years. Br Med J 1992; 309: 609-613.
11. Irvine S, Cawood E, Richardson D, MacDonald E, Aitken J. Evidence for deteriorating semen quality in the United Kingdom; birth cohort s tudy in 577 men in Scotland over 11 years. Br Med J 1996; 312: 467-71.
12. Swan SH, Elkin EP, Fenster L. The question of declining sperm density revisited: an analysis of 101 studies published 1934- 1996. Environ Health Perspect 2000; 108: 961-6.
13. Lackner J, Schatzl G, Waldhör T, Resch K, Kratzik C, Marberger M. Constant decline in sperm concentration in infertile males in an urban population: experience over 19 years. Fertil Steril 2005; 84: 1657-61.
14. Sripada S, Fonseca S, Lee A, Harrild K, Giannaris D, Mathers E et al. Trends in semen parameters in the northeast of Scotland. J Androl 2007; 28: 313-9.
15. Jørgensen N, Asklund C, Carlsen E, Skakkebæk NE. Coordinated European investigations of semen quality: results from studies of Scandinavian young men is a matter of concern. Int J Androl 2006; 29: 54-61.
16. Rhemrev JPT, Lens JW, McDonnell J, Schoemaker J, Vermaiden JPW. The postwash total progressively motile sperm cell count is a reliable predictor of total fertilization failure during in vitro treatment. Fertil Steril 2001; 76: 884-91.
17. Devroey P, Vandervorst M, Nagy P, Van Steirteghem A. Do we treat the male or his gamete? Hum Reprod 1998; 13: 178-85.
18. Tournaye H. Management of male infertility by assisted reproductive technologies. Best Pract Res Clin Endocrinol Metab 2000; 14: 423-435.
19. Staessen C, Camus M, Clasen K, De Vos A, Van Steirteghem A. Conventional in-vitro fertilization versus intracytoplasmic sperm injection in sibling oocytes from couples with tubal infertility and normozoospermic semen. Hum Reprod 1999; 14: 2474-9.
20. Harari O, Bourne H, McDonald M, Riching N, Speirs A, Johnston HW et al. Intracytoplasmic sperm injection: a major advance in the management of severe male subfertility. Fertil Steril 1995; 64: 360-8.
21. Nagy J, Liu J, Joris H, Verheyen G, Tournaye H, Camus M et al. The result of intracytoplasmic sperm injection is not related to any of the three basic sperm parameters. Hum Reprod 1995; 10: 1123-9.
22. de Mendoza MV, Gonzales-Utor AL, Cruz N, Gutierrez P, Cascales F, Sillero JM. In situ use of pentoxifylline to assess sperm vitality in intracytoplasmic sperm injection for treatment of patients with total lack of sperm movement. Fertil Steril 2000; 74: 176-7.
23 Nagy Z. Sperm centriole disfunction and sperm immotility. Mol Cell Endocrinol 2000; 166: 59-62.
24. Nijs M, Vanderzwalmen P, Vandamme B, Segal-Bertin S, Lejeune B, Segal L, et al. Andrology: fertilizing ability of immotile spermatozoa after intracytoplasmic injection. Hum Reprod 1996; 11: 2180-5.